Metformin is the most-prescribed oral medication to lower blood glucose worldwide. But research findings about its association with cardiovascular disease, the most costly complication of type 2 diabetes, remain sparse and difficult to interpret. A new meta-analysis of research on the effect of metformin on cardiovascular outcomes in diabetes patients shows that metformin monotherapy appears […]